Skip to main content

Table 3 Enriched GO (BP) pathways of Safflower and Salvia compounds in MI and CI samples

From: Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L

Description

P value

p.adjust

qvalue

count

Response to reactive oxygen species

1.00E-13

1.87E-10

6.09E-11

10

Positive regulation of cell migration

1.70E-13

1.87E-10

6.09E-11

12

Reactive oxygen species metabolic process

3.35E-13

2.21E-10

7.22E-11

10

Response to oxygen levels

4.03E-13

2.21E-10

7.22E-11

11

Response to oxidative stress

1.91E-12

8.36E-10

2.73E-10

11

Leukocyte migration

4.30E-12

1.57E-09

5.13E-10

11

Response to hypoxia

6.71E-12

1.84E-09

6.02E-10

10

Regulation of smooth muscle cell proliferation

6.73E-12

1.84E-09

6.02E-10

8

Smooth muscle cell proliferation

7.97E-12

1.84E-09

6.02E-10

8

Response to decreased oxygen levels

8.41E-12

1.84E-09

6.02E-10

10

Response to steroid hormone

2.24E-11

4.47E-09

1.46E-09

10

Epithelial cell apoptotic process

3.20E-11

5.86E-09

1.91E-09

7

Regulation of inflammatory response

3.67E-11

6.18E-09

2.02E-09

10

Cellular response to oxidative stress

4.54E-11

6.66E-09

2.17E-09

9

Reactive oxygen species biosynthetic process

4.55E-11

6.66E-09

2.17E-09

7

Response to antibiotic

1.46E-10

1.87E-08

6.10E-09

9

Response to lipopolysaccharide

1.50E-10

1.87E-08

6.10E-09

9

Muscle cell proliferation

1.53E-10

1.87E-08

6.10E-09

8

Negative regulation of apoptotic signaling pathway

1.65E-10

1.91E-08

6.23E-09

8

Cellular response to drug

2.12E-10

2.32E-08

7.57E-09

9